WaveMan · Form 4
Parmar Kush insider trades
> Search tickers & screens ⌘K
LIVE

Parmar Kush insider trades

Parmar Kush has filed 30 Form 4s with the SEC that we hold, for Entrada Therapeutics, Inc. (TRDA) (Director), Rallybio Corp (RLYB) (Director), AKUS (Director, 10% owner) and Vor Biopharma Inc. (VOR) (Director, 10% owner), among 7 companies in all. Across all of them we count 5 purchases worth $25.0M and 23 sales worth $16.5M reported on Form 4. In the last 12 months: 0 purchases ($0) and 6 sales ($3.6M). The largest single trade was a purchase of 615,384 shares of Rallybio Corp worth $8.0M, dated 2021-08-02. The first filing on our record is dated 2021-08-04 and the latest 2026-08-10.

Entrada Therapeutics, Inc. (TRDA)

Director · 12 filings · 15 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-11-02P, purchase reported on Form 4250,000$5.0M2021-11-05
2025-06-27S, sale reported on Form 419,265$133.1K2025-07-01
2025-06-27S, sale reported on Form 455,735$385.1K2025-07-01
2025-06-30S, sale reported on Form 46,422$43.7K2025-07-01
2025-06-30S, sale reported on Form 418,578$126.5K2025-07-01
2025-07-01S, sale reported on Form 46,422$45.7K2025-07-01
2025-07-01S, sale reported on Form 418,578$132.3K2025-07-01
2025-07-09S, sale reported on Form 420,065$150.5K2025-07-11
2025-07-09S, sale reported on Form 46,935$52.0K2025-07-11
2025-11-14S, sale reported on Form 4200,000$1.8M2025-11-18
2026-07-30S, sale reported on Form 4114,756$795.3K2026-08-03
2026-07-31S, sale reported on Form 41,718$11.8K2026-08-03
2026-08-06S, sale reported on Form 410,494$73.5K2026-08-10
2026-08-07S, sale reported on Form 452,317$358.4K2026-08-10
2026-08-10S, sale reported on Form 492,444$647.1K2026-08-10

Rallybio Corp (RLYB)

Director · 11 filings · 8 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-08-02P, purchase reported on Form 4615,384$8.0M2021-08-04
2022-02-08S, sale reported on Form 4139,539$1.8M2022-02-10
2022-02-08S, sale reported on Form 470,461$919.5K2022-02-10
2022-05-23S, sale reported on Form 466,447$863.8K2022-05-25
2022-05-23S, sale reported on Form 433,553$436.2K2022-05-25
2022-06-03S, sale reported on Form 499,671$1.2M2022-06-07
2022-06-03S, sale reported on Form 450,329$629.1K2022-06-07
2023-03-07S, sale reported on Form 4100,000$820.0K2023-03-09

AKUS

Director, 10% owner · 2 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Vor Biopharma Inc. (VOR)

Director, 10% owner · 2 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-11-16S, sale reported on Form 4238,870$3.7M2021-11-18
2021-11-16S, sale reported on Form 491,836$1.4M2021-11-18

CINC

10% owner · 1 filing · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-01-11P, purchase reported on Form 4157,500$2.5M2022-01-13
2022-01-11P, purchase reported on Form 4312,500$5.0M2022-01-13

Q32 Bio Inc. (FIXX)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Skye Bioscience, Inc. (SKYE)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2024-03-13P, purchase reported on Form 4450,000$4.5M2024-03-15
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1664281) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms